11 / 30
SA JOURNAL OF DIABETES & VASCULAR DISEASE
RESEARCH ARTICLE
VOLUME 17 NUMBER 2 • NOVEMBER 2020
47
New-onset hyperglycaemia and acute coronary syndrome: a systematic overview
and meta-analysis.
Curr Diabetes Rev
2010;
6
(2): 102–110.
4. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T,
et al.
Hyperglycaemia and acute coronary syndrome: a scientific statement from the
American Heart Association Diabetes Committee of the Council on Nutrition,
Physical Activity, and Metabolism.
Circulation
2008;
117
(12): 1610–1619.
5. Angeli F, Reboldi G, Poltronieri C, Lazzari L, Sordi M, Garofoli M,
et al.
Hyperglycaemia in acute coronary syndromes: from mechanisms to prognostic
implications.
Ther Adv Cardiovasc Dis
2015;
9
(6): 412–424.
6. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017
ESC guidelines for the management of acute myocardial infarction in patients
presenting with ST-segment elevation: the Task Force for the management of
acute myocardial infarction in patients presenting with ST-segment elevation of
the European Society of Cardiology (ESC).
Eur Heart J
2018;
39
(2): 119–177.
7. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP,
et
al.
Admission glucose and mortality in elderly patients hospitalized with acute
myocardial infarction: implications for patients with and without recognized
diabetes.
Circulation
2005;
111
: 3078–3086
8. Kadri Z, Danchin N, Vaur L, Cottin Y, Guéret P, Zeller M,
et al.
Major impact of
admission glycaemia on 30 day and one year mortality in non-diabetic patients
admitted for myocardial infarction: results from the nationwide French USIC 2000
study.
Heart
2006;
92
(7): 910–915.
9. Monteiro S, Monteiro P, Gonçalves F, Freitas M, Providência LA. Hyperglycaemia
at admission in acute coronary syndrome patients: prognostic value in diabetics
and non-diabetics.
Eur J Cardiovasc Prev Rehabil
2010;
17
(2): 155–159.
10. Gencer B, Rigamonti F, Nanchen D, Klingenberg R, Räber L, Moutzouri E,
et al.
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute
coronary syndrome: A prospective cohort study.
Eur Heart J Acute Cardiovasc
Care
2018; June 1, [epub ahead of print]
11. N’Guetta R, Yao H, Ekou A, N’Cho-Mottoh MP, Angoran I, Tano M,
et al.
Prévalence et caractéristiques des syndromes coronariens aigus dans une
population d’Afrique sub-Saharienne.
Ann Cardiol Angeiol
2016;
65
: 59–63.
12. Kakou-Guikahue M, N’Guetta R, Anzouan-Kacou JB, Kramoh E, N’Dori A, Ba SA,
et al.
Optimizing the management of acute coronary syndromes in sub-Saharan
Africa: a statement from the AFRICARDIO 2015 consensus team.
Arch Cardiovasc
Dis
2016;
109
: 376–383.
13. American Diabetes Association. 2. Classification and diagnosis of diabetes:
standards of medical care in diabetes – 2019.
Diabetes Care
2019;
42
(Suppl 1):
S13–S28.
14. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F,
et al
. 2015
ESC guidelines for the management of acute coronary syndromes in patients
presenting without persistent ST-segment elevation: Task Force for the
Management of Acute Coronary Syndromes in Patients Presenting without
Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).
Eur
Heart J
2016;
37
(3): 267–315.
15. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS,
et al.
2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart
failure: the Task Force for the diagnosis and treatment of acute and chronic heart
failure of the European Society of Cardiology (ESC) developed with the special
contribution of the Heart Failure Association (HFA) of the ESC.
Eur Heart J
2016;
37
(27): 2129–2200.
16. Bahiru E, Temu T, Gitura B, Farquhar C, Huffman MD, Bukachi F. Presentation,
management and outcomes of coronary syndromes: a registry study from
Kenyatta National Hospital in Nairobi, Kenya.
Cardiovasc J Afr
2018;
29
(4): 225–
230.
17. Chen P, Chua S, Hung H, Huang C, Lin C, Lai S,
et al.
Admission hyperglycaemia
predicts poorer short- and long-term outcomes after primary percutaneous
coronary intervention for ST-elevation myocardial infarction.
J Diabetes Investig
2014;
5
: 80–86.
18. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L,
et al.
Glucose
metabolism in patients with acute myocardial infarction and no previous diagnosis
of diabetes mellitus: a prospective study.
Lancet
2002;
359
: 2140–2144.
19. Ishihara M. Acute hyperglycaemia in patients with acute myocardial infarction.
Circ J
2012;
76
: 563–571.
20. Senthinathan A, Kelly V, Dzingina M, Jones D, Baker M, Longson D.
Hyperglycaemia in acute coronary syndromes: summary of NICE guidance.
Br
Med J
2011;
343
: 6646.
21. Tansey MJ, Opie LH. Relation between plasma free fatty acids and arrhythmias
within the first twelve hours of acute myocardial infarction.
Lancet
1983;
2
: 419–
422.
22. Abebe W, Mozaffari M. Endothelial dysfunction in diabetes: Potential application
of circulating markers as advanced diagnostic and prognostic tools.
EPMA J.
2010;
1
(1): 32–45.
23. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart
in diabetes: Part I: General concepts.
Circulation
2002;
105
: 1727–1733.
24. Benalia M, Zeller M, Mouhat B, Guenancia C, Yameogo V, Greco C,
et al.
Glycaemic variability is associated with severity of coronary artery disease in
patients with poorly controlled type 2 diabetes and acute myocardial infarction.
Diabetes Metab
2019;
45
(5): 446–452.
25. Mi SH, Su G1 Yang HX, Zhou Y, Tian L, Zhang T, Tao H. Comparison of in-hospital
glycaemic variability and admission blood glucose in predicting short-term
outcomes in non-diabetes patients with ST elevation myocardial infarction
underwent percutaneous coronary intervention.
Diabetol Metab Syndr
2017;
9
:
20.
26. Vergès B, Avignon A, Bonnet F, Catargi B, Cattan S, Cosson E,
et al.
Consensus
statement on the care of the hyperglycaemic/diabetic patient during and in the
immediate follow-up of acute coronary syndrome.
Diabetes Metab
2012;
38
(2):
113–127.
27. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Metabolic syndrome, undiagnosed
diabetes mellitus and insulin resistance are highly prevalent in urbanised South
African blacks with coronary artery disease.
Cardiovasc J Sth Afr
2006;
17
(2):
50–55.
28. Wang TY, Newby LK, Chen AY, Mulgund J, Roe MT, Sonel AF,
et al.
Hypercholesterolemia paradox in relation to mortality in acute coronary
syndrome.
Clin Cardiol
2009;
32
(9): 22–28.
29. N’Guetta R, Ekou A, Yao H, Anzouan-Kacou JB, Gérardin B, Pillière R,
et al.
Angioplastie coronaire dans les syndromes coronariens aigus en Côte d’Ivoire:
difficultés et résultats.
Ann Cardiol Angeiol
2018;
67
(4): 244–249.
30. Dortimer AC, Shenoy PN, Shiroff RA,
et al
. Diffuse coronary artery disease in
diabetic patients: Fact or fiction?
Circulation
1978;
57
: 133–136.
31. N’Guetta R, Yao H, Ekou A, Séri B, N’Cho-Mottoh MP, Soya E,
et al
. Coronary
artery disease in black African patients with diabetes: Insights from an Ivorian
cardiac catheterization centre.
Arch Cardiovasc Dis
2019;
112
(5): 296–304.
32. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U,
et
al.
2018 ESC guidelines on myocardial revascularization.
Eur Heart J
2019;
40
(2):
87–165.